Please assess the completion status of the following clinical trial:

Trial Title: Early Use of Norepinephrine in Septic Shock Resuscitation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> or = 18 years old~* Diagnosed severe sepsis or septic shock according to survival sepsis campaign 2013~* Mean arterial pressure \< 65 mmHg~Exclusion Criteria:~* Pregnancy~* Severe underlying condition that unexpected to survive more than 48 hours~* Severe peripheral vascular disease~* Patient who required major surgery within 24 hours

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Early norepinephrine (Type: ACTIVE_COMPARATOR): Norepinephrine 4 mg in 5% dextrose water 250 ml Intravenous infusion rate range from 8 to 15 ml/hour, adjusted according to patient's body weight to achieve norepinephrine 0.05microgram/kg/min Continuous drip for 48 hours.
- Placebo (Type: PLACEBO_COMPARATOR): 5% dextrose water 250 ml Intravenous infusion rate range from 8 to 15 ml/hour. Adjust rate of infusion according to patient's body weight to achieve dosage of norepinephrine comparable to 0.05 microgram/kg/min Continuous drip for 48 hours.

Based on this trial design, predict the completion outcome and termination type (if applicable).